Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

To determine how accurately and reproducibly small doses are delivered, 1, 2, 5, and 10 U doses of soluble insulin (100 U/ml) were dispensed in random order 15 times from five new NovoPens (1.5 ml), ...

All the latest news, photos and more on King Juan Carlos, Queen Sofia Find out more about the Spanish Royal Family tree The wife of King Felipe of Spain recycled her beloved Carolina Herrera suit ...

Access the latest market prices for European shares and products to make trading decisions with confidence.